A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders

NCT00650611 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Bipolar Disorder
Schizoaffective Disorder

Interventions

DRUG: Ziprasidone
DRUG: Ziprasidone

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.